Participation of the Limbic System in the Treatment of Parkinson's Disease with Depression

Authors

  • Feng Chen Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Ni Jia Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi, China
  • Yangmei Ye Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Niannian Li Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Jianing He Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China

DOI:

https://doi.org/10.53469/jcmp.2024.06(08).25

Keywords:

Limbic system, Parkinson's disease, Depression, Review

Abstract

Parkinson's disease (PD) is a common chronic neurological disease in the elderly, starting from motor disorders such as static tremor and bradykinesia. However, with the evolution of the disease, the incidence of non-motor symptoms increases year by year, among which it is mainly depression. With the emergence of depressive symptoms, seriously affected the quality of life of PD patients, but also induce aggravating movement disorders and a series of related symptoms, for the pathogenesis of PD patients with depression is not clear, most people think it with the brain of dopamine, serotonergic neurons change, this paper will start on the brain structure, from the ancient limbic system, its definition and structure, and the mechanism between PD patients with depression, through consulting relevant literature, expand the following review.

References

Raza C, Anjum R, Shakeel NUA. Parkinson's disease: Mechanisms, translational models and management strategies. Life Sci.2019 Jun 1;226:77-90.

Marsh L. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep.2013 Dec; 13(12):409.

Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord.2008;23:183-189.quiz 313.

Schrag A, Taddei RN. Depression and Anxiety in Parkinson's Disease. Int Rev Neurobiol. 2017;133:623-655.

Su W, Liu H, Jiang Y,et al. Correlation between depression and quality of life in patients with Parkinson's disease. Clin Neurol Neurosurg.2021 Mar;202:106523.

Dragaševi ć -Mi š kovi ć NT, Bobi ć V, Kosti ć M, et al. Impact of depression on gait variability in Parkinson's disease. Clin Neurol Neurosurg.2021 Jan;200:106324.

Assogna F, Pellicano C, Savini C, et al. Drug Choices and Advancements for Managing Depression in Parkinson's Disease. Curr Neuropharmacol. 2020;18(4):277-287.

Zhang Xuehui, Zou Hong, Zhou Yiren, etc. Progress in the involvement of cerebral limbic system in acupuncture treatment of chronic pain [J]. Acupuncture study, 2020,45 (04): 339-345.

Banwinkler M, Theis H, Prange S, et al. Imaging the Limbic System in Parkinson's Disease-A Review of Limbic Pathology and Clinical Symptoms. Brain Sci.2022 Sep 15;12(9):1248.

Roxo M.R., Franceschini P.R., Zubaran C., et al. The Limbic System Conception and Its Historical Evolution. Science.2011;11:2427-2440.

Roxo MR, Franceschini PR, Zubaran C, et al. The limbic system conception and its historical evolution. ScientificWorldJournal.2011;11:2428-41.

Mark L.P., Daniels D.L., Naidich T.P., et al. Limbic Connections. AJNR Am. J. Neuroradiol.1995;16:1303

Eric J. Nestler et al. Neurobiology of Depression [J]. Neuron, 2002, 34(1) : 13-25.

Whalen PJ, Phelps EA. The human amygdala. New York, NY: The Guilford Press; 2009

Smith DM, Torregrossa MM. Valence encoding in the amygdala influences motivated behavior. Behav Brain Res.2021 Aug 6;411:113370.

Janak PH, Tye KM. From circuits to behaviour in the amygdala.Nature.2015 Jan 15;517(7534):284-92.

Liao H, Yi J, Cai S, et al. Changes in Degree Centrality of Network Nodes in Different Frequency Bands in Parkinson's Disease With Depression and Without Depression. Front Neurosci.2021 Mar 22;15:638554.

Qu Hongying, Gao Yong'an, Liang Peipeng, etc. Imaging study of structural and functional abnormalities in the amygdala with depression in patients with Parkinson's disease [J]. Journal of Medical Imaging, 2017,27 (01): 154-157.

Huang P, Xuan M, Gu Q, et al. Abnormal amygdala function in Parkinson's disease patients and its relationship to depression. J Affect Disord.2015 Sep 1;183:263-8.

Hu X, Song X, Yuan Y, et al. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease. Mov Disord.2015 Feb;30(2):238-44.

Rolls ET. The cingulate cortex and limbic systems for emotion, action, and memory. Brain Struct Funct.2019 Dec;224(9):3001-3018.

Hamani C, Mayberg H, Stone S, et al. The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry.2011;69(4):301-308

Laxton AW, Neimat JS, Davis KD, et al. Neuronal coding of implicit emotion categories in the subcallosal cortex in patients with depression. Biol Psychiatry. 2013;74(10):714-719.

Rolls ET. The storage and recall of memories in the hippocampo-cortical system. Cell Tissue Res. 2018;373:577-604

Rolls ET.The orbitofrontal cortex and emotion in health and disease, including depression. Neuropsychologia. 2019;128:14-43.

Wei L, Hu X, Yuan Y, et al. Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson's disease with depression. Behav Brain Res. 2018 Jul 16;347:132-139.

A. C. Peterson, S. Zhang, S.E.et al, The Effects of Age, from Young to Middle Adulthood, and Gender on Resting State Functional Connectivity of the Dopaminergic Midbrain, Frontiers in human neuroscience 11 (2017)

Alkemade A, Forstmann BU. Imaging of the human subthalamic nucleus. Handb Clin Neurol. 2021;180:403-416.

Temel Y, Boothman LJ, Blokland A, et al. Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci U S A.2007 Oct 23;104(43):17087-92.

Rappel P, Grosberg S, Arkadir D, et al.Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus. Mov Disord.2020 Feb;35(2):337-343.

Sun Y, Wang Z, Hu K, et al.α and θ oscillations in the subthalamic nucleus are potential biomarkers for Parkinson's disease with depressive symptoms. Parkinsonism Relat Disord.2021 Sep; 90:98-104.

Tartt AN, Mariani MB, Hen R, et al. Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications. Mol Psychiatry.2022 Jun;27(6):2689-2699.

Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology.2001;25(6):836-844.

Wakade CG, Mahadik SP, Waller JL, et al. Atypical neuroleptics stimulate neurogenesis in adult rat brain. Journal of Neuroscience Research.2002;69(1):72-79.

Bortolotto V, Cuccurazzu B, Canonico PL, et al.NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity. Biomed Res Int.2014;2014:612798.

Albensi BC, Mattson MP. Evidence for the involvement of TNF and NF-κ B in hippocampal synaptic plasticity. Synapse.2000;35(2):151-159.

Györfi O, Nagy H, Bokor M, et al. Reduced CA2-CA3 Hippocampal Subfield Volume Is Related to Depression and Normalized by l-DOPA in Newly Diagnosed Parkinson's Disease. Front Neurol.2017 Mar 17;8:84.

Yang W, Yu S. Synucleinopathies: common features and hippocampal manifestations. Cell Mol Life Sci.2017 Apr;74(8):1485-1501.

Zhang Y, Roy DS, Zhu Y, et al. Targeting thalamic circuits rescues motor and mood deficits in PD mice. Nature.2022 Jul;607(7918):321-329.

Downloads

Published

2024-08-21

How to Cite

Chen, F., Jia, N., Ye, Y., Li, N., & He, J. (2024). Participation of the Limbic System in the Treatment of Parkinson’s Disease with Depression. Journal of Contemporary Medical Practice, 6(8), 122–126. https://doi.org/10.53469/jcmp.2024.06(08).25